Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

2.5K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Particulate hexavalent chromium exposure induces DNA double-strand breaks and inhibits homologous recombination repair in rat and human lung tissues.

Chemosphere·2024
Same author

Surgical resection of micronodular thymic carcinoma with lymphoid hyperplasia: a case report.

General Thoracic and Cardiovascular Surgery Cases·2024
Same author

Impact of interstitial lung disease gender-age-physiology index in surgically treated lung cancer.

International journal of clinical oncology·2024
Same author

DNA methylation and mRNA expression of ZNF577 as biomarkers for the detection and prognosis of lung adenocarcinoma.

Oncology reports·2024
Same author

Symptomatic adverse events of chemotherapy in breast cancer patients:Using CTCAE, PRO-CTCAE, and EORTC QLQ-C30.

The journal of medical investigation : JMI·2024
Same author

Hexavalent chromium exposure activates the non-canonical nuclear factor kappa B pathway to promote immune checkpoint protein programmed death-ligand 1 expression and lung carcinogenesis.

Cancer letters·2024

Related Experiment Video

Updated: Apr 28, 2026

Isolation, Identification, and Purification of Murine Thymic Epithelial Cells
07:20

Isolation, Identification, and Purification of Murine Thymic Epithelial Cells

Published on: August 8, 2014

32.4K

Therapy for thymic epithelial tumors.

Kazuya Kondo1

  • 1Department of Oncological Medical Services, Institute of Health Biosciences, The University of Tokushima Graduate School, 18-15 Kuramoto-cho 3, Tokushima, 770-8509, Japan, kzykondo@medsci.tokushima-u.ac.jp.

General Thoracic and Cardiovascular Surgery
|June 11, 2014
PubMed
Summary
This summary is machine-generated.

Thymoma, a common anterior mediastinum tumor, has optimal treatment strategies evolving with new classifications. Surgery is key, with multimodality therapy improving outcomes for advanced thymoma stages.

More Related Videos

Complete Thymectomy in Adult Rats with Non-invasive Endotracheal Intubation
08:35

Complete Thymectomy in Adult Rats with Non-invasive Endotracheal Intubation

Published on: December 29, 2014

16.2K
In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
07:02

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice

Published on: August 23, 2019

7.1K

Related Experiment Videos

Last Updated: Apr 28, 2026

Isolation, Identification, and Purification of Murine Thymic Epithelial Cells
07:20

Isolation, Identification, and Purification of Murine Thymic Epithelial Cells

Published on: August 8, 2014

32.4K
Complete Thymectomy in Adult Rats with Non-invasive Endotracheal Intubation
08:35

Complete Thymectomy in Adult Rats with Non-invasive Endotracheal Intubation

Published on: December 29, 2014

16.2K
In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
07:02

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice

Published on: August 23, 2019

7.1K

Area of Science:

  • Oncology
  • Thoracic Surgery
  • Pathology

Background:

  • Thymoma is the most common anterior mediastinum tumor, often linked to paraneoplastic syndromes.
  • Optimal treatment for thymoma remains challenging due to its rarity.
  • Advancements in classification systems, including WHO and Masaoka, improve understanding and prognosis prediction.

Purpose of the Study:

  • To review the current understanding and optimal treatment strategies for thymoma.
  • To highlight the importance of staging and classification in guiding therapeutic decisions.
  • To discuss the role of surgery, radiotherapy, and chemotherapy in managing thymoma.

Main Methods:

  • Review of existing literature on thymoma classification and treatment.
  • Analysis of current surgical approaches, including minimally invasive techniques.
  • Evaluation of the efficacy of adjuvant therapies like radiotherapy and chemotherapy.

Main Results:

  • The Masaoka classification is a widely accepted prognostic predictor.
  • Surgery is the primary treatment for thymic epithelial tumors.
  • Multimodality therapy shows promise for advanced thymoma stages (III and IV).

Conclusions:

  • Treatment decisions for thymoma should be based on clinical stage.
  • Minimally invasive surgery is increasingly used for early-stage thymomas.
  • Combined modality treatment may enhance resection rates and survival in advanced thymoma.